Not available
Quote | Surface Oncology Inc. (NASDAQ:SURF)
Last: | $1.07 |
---|---|
Change Percent: | 0.93% |
Open: | $1.06 |
Close: | $1.07 |
High: | $1.09 |
Low: | $1.01 |
Volume: | 1,510,170 |
Last Trade Date Time: | 09/07/2023 03:00:00 am |
News | Surface Oncology Inc. (NASDAQ:SURF)
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Surface Oncology Inc. (SURF) is expected to report $-0.36 for Q3 2023
Message Board Posts | Surface Oncology Inc. (NASDAQ:SURF)
Subject | By | Source | When |
---|---|---|---|
Does this take off soon? | B4I8ahat | investorshub | 02/25/2023 10:28:49 PM |
So quiet??? | JHOGG | investorshub | 08/31/2022 1:38:10 AM |
Why do quiet here? | JHOGG | investorshub | 08/31/2022 1:37:09 AM |
$SURF...$4.43...Bullish Harami Cross Reversal pattern to the Upside... | georgie18 | investorshub | 01/12/2022 12:03:07 PM |
$SURF...$5.02s clearing here on the Piercing Line Reversal | georgie18 | investorshub | 12/28/2021 3:11:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Surface Oncology Inc. Company Name:
SURF Stock Symbol:
NASDAQ Market:
Surface Oncology Inc. Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Surface Oncology Inc. (SURF) is expected to report $-0.36 for Q3 2023
CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (Nasdaq: SURF) (“Surface”), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that both Institutional Shareholder Serv...